PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test

AUAUniversity

English - December 15, 2023 06:30 - 52 minutes - 48.3 MB - ★★★★★ - 32 ratings
Courses Education Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Infectious Complications Following Prostate Biopsy

Next Episode: Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)

CME Available: https://auau.auanet.org/node/39603
Release Date: December, 2023
Expiration Date: December, 2024

LEARNING OBJECTIVES:
At the conclusion of this activity, the learner will be able to:
1. Review recommended criteria for genetic testing of prostate cancer patients, currently available gene panels, and options for testing these men.
2. Explain the importance of testing for germline and somatic mutations and their implications for utilizing PARPi.
3. Describe work flows for genetic testing and utilization of genetic counselors.
4. Describe the genetic counseling process and the importance of pre-test counseling to discuss the benefits, limitations, and potential implications of germline testing for patients and their families.

ACKNOWLEDGEMENT
This educational activity is supported by an independent educational grant from Pfizer, Inc.